Literature DB >> 7172985

Implanting the glucose enzyme electrode: problems, progress, and alternative solutions.

S J Updike, M Shults, B Ekman.   

Abstract

An implantable glucose sensor is needed before a reliable artificial pancreas can be realized. The principles and current status of one such device, the glucose enzyme electrode, is presented and discussed. While monitoring glucose this enzyme sensor consumes enough oxygen to become oxygen-limited. This problem has been solved by developing hydrophobic membranes that are more permeable to oxygen than to glucose. Two types of membranes with this property made from (1) cross-linked albumin and (2) sebacyl chloride (nylon) are described. Placing these membranes over the glucose enzyme electrode solves the problem of oxygen limitation. Furthermore, the addition of this type of membrane increases the linear response range of the electrode to glucose to include the entire clinical range of interest (0-400 mg/dl). Other problems in developing an implantable glucose sensor are discussed. Competing strategies to achieve an implantable artificial pancreas without using electronic or mechanical components are presented and evaluated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7172985     DOI: 10.2337/diacare.5.3.207

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs.

Authors:  U Fischer; R Ertle; P Abel; K Rebrin; E Brunstein; H Hahn von Dorsche; E J Freyse
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

2.  [Biosensors].

Authors:  H L Schmidt; R Kittsteiner-Eberle
Journal:  Naturwissenschaften       Date:  1986-06

Review 3.  Haemocompatibility of invasive sensors.

Authors:  Y Benmakroha; S Zhang; P Rolfe
Journal:  Med Biol Eng Comput       Date:  1995-11       Impact factor: 2.602

4.  Immobilized glucose oxidase in the potentiometric detection of glucose.

Authors:  L B Wingard; J F Castner; S J Yao; S K Wolfson; A L Drash; C C Liu
Journal:  Appl Biochem Biotechnol       Date:  1984-02       Impact factor: 2.926

5.  A percutaneous device as model to study the in vivo performance of implantable amperometric glucose sensors.

Authors:  M Gerritsen; A Kros; J A Lutterman; R J Nolte; J A Jansen
Journal:  J Mater Sci Mater Med       Date:  2001-02       Impact factor: 3.896

6.  Impact of CCL2 and CCR2 chemokine/receptor deficiencies on macrophage recruitment and continuous glucose monitoring in vivo.

Authors:  Ulrike Klueh; Caroline Czajkowski; Izabela Ludzinska; Yi Qiao; Jackman Frailey; Donald L Kreutzer
Journal:  Biosens Bioelectron       Date:  2016-06-23       Impact factor: 10.618

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.